Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Stemtech's operating income for the twelve months ending Sep 30, 2026 was -$2.46M. For fiscal 2025 it was -$2.71M. The highest annual figure on record is -$16.64K in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.71M | – |
| FY2024 | Dec 31, 2024 | -$2.39M | – |
| FY2023 | Dec 31, 2023 | -$4.22M | – |
| FY2022 | Dec 31, 2022 | -$5.02M | – |
| FY2021 | Dec 31, 2021 | -$3.21M | – |
| FY2019 | Aug 31, 2019 | -$20.15K | – |
| FY2018 | Aug 31, 2018 | -$24.82K | – |
| FY2017 | Aug 31, 2017 | -$36.49K | – |
| FY2016 | Aug 31, 2016 | -$23.53K | – |
| FY2015 | Aug 31, 2015 | -$16.64K | – |
| FY2014 | Aug 31, 2014 | -$35.33K | – |
| FY2013 | Aug 31, 2013 | -$28.59K | – |
| FY2012 | Aug 31, 2012 | -$27.56K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$371.40K | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$125.57K | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$1.09M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$863.94K | -2705.1% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$339.22K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$300.99K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$1.20M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $33.16K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$716.47K | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$692.31K | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$1.01M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$1.43M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$578.99K | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$967.60K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.25M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$432.24K | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$3.38M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$1.03M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$180.52K | – |
| Q3 FY2021CQ3 2020 | May 31, 2021 | -$3.65K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$75.09K | – |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -$8.84K | – |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -$3.55K | – |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -$4.76K | – |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -$2.99K | – |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -$7.30K | – |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -$4.08K | – |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -$5.77K | – |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -$7.67K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -$13.89K | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -$8.75K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -$8.29K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -$5.56K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -$9.68K | – |
| Q3 FY2016CQ2 2016 | May 31, 2016 | -$6.57K | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | -$2.49K | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | -$4.79K | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | -$7.25K | – |
See a number that looks wrong?